Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · IEX Real-Time Price · USD
3.390
-0.390 (-10.32%)
At close: Jul 2, 2024, 4:00 PM
3.580
+0.190 (5.60%)
After-hours: Jul 2, 2024, 5:20 PM EDT
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $34.82 million as of July 2, 2024. Its market cap has increased by 18.02% in one year.
Market Cap
34.82M
Enterprise Value
28.97M
1-Year Change
18.02%
Ranking
Category
Stock Price
$3.39
Market Cap Chart
Since February 5, 2021, Elicio Therapeutics's market cap has decreased from $489.80M to $34.82M, a decrease of -92.89%. That is a compound annual growth rate of -53.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 34.80M | -50.36% |
| Dec 29, 2023 | 70.10M | 187.30% |
| Dec 30, 2022 | 24.40M | -71.92% |
| Dec 31, 2021 | 86.90M | -82.26% |
| Feb 5, 2021 | 489.80M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Augmedix | 43.09M |
| Lucid Diagnostics | 42.98M |
| vTv Therapeutics | 42.96M |
| Protara Therapeutics | 42.83M |
| Ocean Biomedical | 42.27M |
| Atara Biotherapeutics | 41.69M |
| Moolec Science | 41.32M |
| AEON Biopharma | 41.08M |